Cytochroma settles lawsuit with Genzyme
The lawsuit, in which Genzyme claimed that the former Bone Care employees had begu...Third Wave responds to Digene patent lawsuit
(HPV) and would continue to develop products to detect high-risk infections.<...Merge's merger is the crux of shareholder lawsuits
Alleging that members of its management team violated federal securities law, shareholders of , a developer of medical imaging and information management software, have filed se...Third Wave agrees to drop Chiron, Bayer patent lawsuits
Third Wave said that no licenses or payments were made and did not disclose other terms of the agreement. This leaves Third Wave with only one remaining open patent...Third Wave licenses Innogenetics tech to settle lawsuit
The two companies' relationship goes back further. In Aril 2004 Third Wave forged a deal under which Innogenetics was an exclusive distributor...Third Wave wins patent lawsuit against California firm
The decision, which was passed by a federal jury in the United...Californian stem-cell efforts get new rules, attract lawsuits
The leaders of California's $3 billion bond initiative to fund stem-cell research, under pressure from advocacy groups, have voted in new rules against conflicts of interest. Ten of the initiative's 29 board members hold significant stock in or serve on the boards of biotech companies, the Sacramento Bee reported. They won't have to relinquish stock or their positions, but employees of t...